Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Brian B
This section directly addresses the critical gap between animal research and established clinical efficacy
Refrigerated storage following reconstitution
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
The most commonly reported side effect is irritation of the area where the injection is administered. If this occurs, consider changing placement on the body or use injections less often
A history of flushing, hypotension, and diarrhea is classic for metastatic neuroendocrine tumors such as carcinoids
US$ 26.00
US$ 28.32
US$ 25.80